Monday, January 19, 2026 7:27:45 PM
exwannabe,
Tell the rest of the story. Ms Wolfe was removed from Ondra as a partner for her conflict of interest indiscretion as primary information gathering employee of Ondra in interactions with NWBO and likely share of that non public information with Mr. Woodford. Ondra is a company that was presented as focused on value enhancement for creating investor interest and imposed upon NWBO as a requirement for funding by the Woodford group. This is likely the information which the Woodford group spokesperson at the time disclosed indirectly as information gathered during the course of doing due diligence on NWBO which left the Woodford group apparently unwilling to buy, sell or trade NWBO stock until there was a change in fiduciary.
Mr. Woodford’s initial attempt to save face was a threat to do an investigation of NWBO after his suggestion for an addition to the board of NWBO was refused. Nothing ever came of his threat but he never traded NWBO stock again except to fulfill a previously made contractual obligation to fund NWBO for the last time in November 2015. His replacement sold NWBO shares at fire sale prices instead of at much higher prices that were still around soon after his debacle while he was still fiduciary. His replacement never did an investigation either. If there was anything to investigate that was probably shared by Mr. Cofer Black with Mr. Woodford and regulators at which point there was no further threat from him about an investigation of NWBO or selling of NWBO by his funds until he was replaced.
Paul Harvey loved telling the rest of the story. I’m guessing you aren’t a fan and are glad he’s not around to look into the story of NWBO and all those opposed to its success ; ). Best wishes.
Tell the rest of the story. Ms Wolfe was removed from Ondra as a partner for her conflict of interest indiscretion as primary information gathering employee of Ondra in interactions with NWBO and likely share of that non public information with Mr. Woodford. Ondra is a company that was presented as focused on value enhancement for creating investor interest and imposed upon NWBO as a requirement for funding by the Woodford group. This is likely the information which the Woodford group spokesperson at the time disclosed indirectly as information gathered during the course of doing due diligence on NWBO which left the Woodford group apparently unwilling to buy, sell or trade NWBO stock until there was a change in fiduciary.
Mr. Woodford’s initial attempt to save face was a threat to do an investigation of NWBO after his suggestion for an addition to the board of NWBO was refused. Nothing ever came of his threat but he never traded NWBO stock again except to fulfill a previously made contractual obligation to fund NWBO for the last time in November 2015. His replacement sold NWBO shares at fire sale prices instead of at much higher prices that were still around soon after his debacle while he was still fiduciary. His replacement never did an investigation either. If there was anything to investigate that was probably shared by Mr. Cofer Black with Mr. Woodford and regulators at which point there was no further threat from him about an investigation of NWBO or selling of NWBO by his funds until he was replaced.
Paul Harvey loved telling the rest of the story. I’m guessing you aren’t a fan and are glad he’s not around to look into the story of NWBO and all those opposed to its success ; ). Best wishes.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
